TELEFLEX INC (TFX) Stock Price, Forecast & Analysis
USA • New York Stock Exchange • NYSE:TFX • US8793691069
TFX Key Statistics, Chart & Performance
The current stock price of TFX is 102.37 USD. In the past month the price decreased by -17.75%. In the past year, price decreased by -40.17%.
TFX Technical Analysis
TFX Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to TFX. TFX has an average financial health and profitability rating.
TFX Financial Highlights
Over the last trailing twelve months TFX reported a non-GAAP Earnings per Share(EPS) of 14.2. The EPS increased by 5.19% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.17% | ||
| ROE | -8.58% | ||
| Debt/Equity | 0.67 |
TFX Forecast & Estimates
21 analysts have analysed TFX and the average price target is 141.92 USD. This implies a price increase of 38.63% is expected in the next year compared to the current price of 102.37.
For the next year, analysts expect an EPS growth of 1.3% and a revenue growth 7.4% for TFX
TFX Ownership
TFX Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 19.01 | 189.572B | ||
| ISRG | INTUITIVE SURGICAL INC | 48.2 | 169.763B | ||
| SYK | STRYKER CORP | 23.86 | 137.985B | ||
| BSX | BOSTON SCIENTIFIC CORP | 26.16 | 135.821B | ||
| BDX | BECTON DICKINSON AND CO | 13.75 | 58.939B | ||
| IDXX | IDEXX LABORATORIES INC | 42.69 | 50.51B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.73 | 47.643B | ||
| RMD | RESMED INC | 20.47 | 36.698B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.65 | 35.886B | ||
| DXCM | DEXCOM INC | 28.46 | 27.937B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About TFX
Company Profile
Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania and currently employs 14,100 full-time employees. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Company Info
TELEFLEX INC
550 E Swedesford Rd, Suite 400
Wayne PENNSYLVANIA 19087 US
CEO: Liam J. Kelly
Employees: 14100
Phone: 16102256800
TELEFLEX INC / TFX FAQ
What does TELEFLEX INC do?
Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania and currently employs 14,100 full-time employees. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
What is the current price of TFX stock?
The current stock price of TFX is 102.37 USD. The price decreased by -0.96% in the last trading session.
Does TFX stock pay dividends?
TELEFLEX INC (TFX) has a dividend yield of 1.29%. The yearly dividend amount is currently 1.36.
What is the ChartMill technical and fundamental rating of TFX stock?
TFX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the analyst forecast for TFX stock?
21 analysts have analysed TFX and the average price target is 141.92 USD. This implies a price increase of 38.63% is expected in the next year compared to the current price of 102.37.
What is the expected growth for TFX stock?
The Revenue of TELEFLEX INC (TFX) is expected to grow by 7.4% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for TELEFLEX INC?
TELEFLEX INC (TFX) has a market capitalization of 4.52B USD. This makes TFX a Mid Cap stock.